New York, May 21, 2015 -- Moody's Investors Services today placed the ratings of Omnicare, Inc. ("Omnicare") under review for upgrade, including the company's Ba3 Corporate Family Rating and Ba3-PD Probability of Default Rating. Moody's concurrently affirmed Omnicare's Speculative Grade Liquidity rating of SGL-3. This action follows today's announcement that Omnicare has entered into a definitive agreement to be acquired by CVS Health (CVS, Baa1 Stable Outlook) in a transaction valued at $12.7 billion. The proposed acquisition is expected to be funded through the issuance of new debt. The transaction is expected to close near the end of 2015.

Vollständigen Artikel bei Moodys lesen